| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
158,300,000 |
| Market
Cap: |
21.34(B) |
| Last
Volume: |
5,362,724 |
Avg
Vol: |
1,539,306 |
| 52
Week Range: |
$70.3 - $144.22 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 6.1 |
| Insider 6 Months : 6.1 |
| Insider 3/6 Months : 12.6 |
|
| Guru Rank Number : 509 |
| Guru Rank Value : 3.8 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
500 |
500 |
18,950 |
26,280 |
| Total Buy Value |
$61,065 |
$61,065 |
$1,555,120 |
$2,546,792 |
| Total People Bought |
1 |
1 |
3 |
3 |
| Total Buy Transactions |
1 |
1 |
4 |
5 |
| Total Shares Sold |
872 |
872 |
872 |
872 |
| Total Sell Value |
$114,926 |
$114,926 |
$114,926 |
$114,926 |
| Total People Sold |
2 |
2 |
2 |
2 |
| Total Sell Transactions |
2 |
2 |
2 |
2 |
| End Date |
2025-09-21 |
2025-06-20 |
2024-12-20 |
2023-12-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Davies Scott M |
Chief Legal Officer |
• • – |
2025-12-12 |
4 |
S |
$136.09 |
$43,957 |
D/D |
(323) |
17,887 |
|
3% |
|
| Wedel Christensen Jakob |
SVP, Strategy/Corp Development |
• • – |
2025-12-08 |
4 |
S |
$129.27 |
$70,969 |
D/D |
(549) |
10,952 |
|
-3% |
|
| Wedel Christensen Jakob |
SVP, Strategy/Corp Development |
• • – |
2025-12-05 |
4 |
D |
$128.96 |
$39,591 |
D/D |
(307) |
11,501 |
|
- |
|
| Davies Scott M |
Chief Legal Officer |
• • – |
2025-11-12 |
4 |
D |
$122.79 |
$39,661 |
D/D |
(323) |
18,210 |
|
- |
|
| Ericksen Scott D |
VP, Chief Accounting Officer |
• • – |
2025-11-05 |
4 |
D |
$122.44 |
$25,223 |
D/D |
(206) |
13,486 |
|
- |
|
| Pegels Kevin Carl |
Chief of Global Operations |
• • – |
2025-11-05 |
4 |
D |
$122.44 |
$73,342 |
D/D |
(599) |
22,476 |
|
- |
|
| Davies Scott M |
Chief Legal Officer |
• • – |
2025-11-05 |
4 |
D |
$122.44 |
$48,731 |
D/D |
(398) |
18,533 |
|
- |
|
| Barnard Steven |
SVP, Chief Technology Officer |
• • – |
2025-11-05 |
4 |
D |
$122.44 |
$63,057 |
D/D |
(515) |
33,031 |
|
- |
|
| Leckman Patricia |
SVP, Chief People Officer |
• • – |
2025-11-05 |
4 |
D |
$122.44 |
$36,242 |
D/D |
(296) |
19,391 |
|
- |
|
| Gottlieb Scott |
Director |
• • – |
2025-11-03 |
4 |
B |
$122.13 |
$61,065 |
D/D |
500 |
12,523 |
2.39 |
9% |
|
| Thaysen Jacob |
Chief Executive Officer |
• • – |
2025-10-05 |
4 |
D |
$101.02 |
$131,427 |
D/D |
(1,301) |
82,089 |
|
- |
|
| Ullem Scott B. |
Director |
• • – |
2025-09-30 |
4 |
A |
$99.17 |
$24,990 |
D/D |
252 |
8,389 |
|
- |
|
| Barnard Steven |
SVP, Chief Technology Officer |
• • – |
2025-09-05 |
4 |
D |
$98.93 |
$28,393 |
D/D |
(287) |
33,546 |
|
- |
|
| Cunningham Everett |
SVP, Chief Commercial Officer |
• • – |
2025-07-05 |
4 |
D |
$97.15 |
$412,693 |
D/D |
(4,248) |
41,942 |
|
- |
|
| Ullem Scott B. |
Director |
• • – |
2025-06-30 |
4 |
A |
$81.20 |
$24,928 |
D/D |
307 |
8,137 |
|
- |
|
| Meister Keith |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
4,405 |
|
- |
|
| Epstein Robert S |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
22,139 |
|
- |
|
| Arnold Frances |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
20,907 |
|
- |
|
| Schiller Philip W |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
20,148 |
|
- |
|
| Ullem Scott B. |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
7,830 |
|
- |
|
| Dorsa Caroline |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
15,194 |
|
- |
|
| Siegel Susan E |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
14,463 |
|
- |
|
| Richo Anna |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
6,455 |
|
- |
|
| Gottlieb Scott |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
12,023 |
|
- |
|
| Guthart Gary S |
Director |
• • – |
2025-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
16,430 |
|
- |
|
1175 Records found
|
|
Page 1 of 47 |
|
|
4.27 (3.27%) 
